Sharp differences in mortality rates and costs related to alcohol-associated hepatitis before and after the COVID-19 pandemic ...

The 5th Circuit Court of Appeals has temporarily restored a rule the FDA lifted in 2023 that requires mifepristone to be ...

Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...

The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher ...

AI highlighted evidence-based research when asked about the safety of acetaminophen use during pregnancy, according to data ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

In this video, Aaron M. Drucker, MD, ScM, FRCPC, FAAD, discusses some of the new molecules coming for atopic dermatitis that ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

In 2026, the biggest drivers of market trends in ophthalmology include rare diseases as well as gene therapies and AI, ...

BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal ...

A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...

Certain demographic and socioeconomic factors were associated with no-show rates for dermatology appointments, according to a ...